Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells-Reference-Cited by-同舟云学术

Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells

Published:2019-05 Issue:5 Volume:21 Page:566-578
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

WANG LEI,GONG WENJIE,WANG SANMEI,NEUBER BRIGITTE,SELLNER LEOPOLD^ORCID,SCHUBERT MARIA-LUISA,HÜCKELHOVEN-KRAUSS ANGELA,KUNZ ALEXANDER,GERN ULRIKE,MICHELS BIRGIT,HINKELBEIN MANDY,MECHLER STEFANIE,RICHTER PETRA,MÜLLER-TIDOW CARSTEN,SCHMITT MICHAEL,SCHMITT ANITA

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference49 articles.

1. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia;Brentjens;Sci Transl Med,2013

2. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias;Brentjens;Blood,2011

3. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study;Cruz;Blood,2013

4. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N Engl J Med,2013

5. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia;Kalos;Sci Transl Med,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study;Leukemia;2024-08-27

2. In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation;International Journal of Molecular Sciences;2024-01-23

3. The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation;Cancer Cell International;2023-12-18

4. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial;Journal of Hematology & Oncology;2023-07-22

5. Impact of serum‑free media on the expansion and functionality of CD19.CAR T‑cells;International Journal of Molecular Medicine;2023-05-26